Neuroimaging Findings in a Brain With Niemann–Pick Type C Disease  by Huang, Jei-Yie et al.
J Formos Med Assoc | 2011 • Vol 110 • No 8 537
Contents lists available at ScienceDirect
Journal of the Formosan Medical Association
Journal homepage: http://www.jfma-online.com
J Formos Med Assoc 2011;110(8):537–542
Journal of the 
Formosan Medical Association
ISSN 0929 6646
Formosan Medical Association
Taipei, Taiwan
Volume 110 Number 8 August 2011
Resveratrol for prophylaxis of ischemic stroke
Microglia and chronic pain
ART in HIV-1-discordant couples in Taiwan
Prognostic evaluation of patients with multicentric papillary thyroid
 microcarcinoma
Case Report
Neuroimaging Findings in a Brain With
Niemann–Pick Type C Disease
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Ruoh-Fang Yen1*
Niemann-Pick type C disease (NPC) is a rare autosomal recessive lipid storage disorder caused by 
impaired cellular functions in processing and transporting low-density lipoprotein–cholesterol. In this 
report, we present magnetic resonance imaging (MRI), magnetic resonance spectrography (MRS) and 
18-fluoro-2-deoxyglucose positron emission tomography (PET) imaging results for a 22-year-old male
NPC patient. The patient’s two MRI studies (at age 19 years and 22 years) demonstrated progressive
changes of brain atrophy that were more prominent at the frontal lobes, and hyperintense signals in bilat-
eral parietal–occipital periventricular white matter. MRS (at age 19 years) revealed no significant decrease
in N-acetyl aspartate/choline ratio in the left frontal central white matter. PET (at age 22 years) showed sig-
nificant bilateral hypometabolism in the prefrontal cortex and dorsomedial thalamus, and hypermetabolism
in the parietal–occipital white matter, lenticular nucleus of the basal ganglia, cerebellum and pons. The
imaging findings noted by MRI, MRS and 18-fluoro-2-deoxyglucose PET offered a possible supplementary
explanation for the clinical neurological symptoms of this NPC patient.
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Niemann-Pick type C disease (NPC) is a rare au-
tosomal recessive lipid storage disorder caused
by impaired cellular functions in processing and
transporting low-density lipoprotein–cholesterol.1
Prevalence of this disease in western countries
has been estimated to be approximately 1 in
100,000.1 Fewer than 10 cases have been reported
in Taiwan to date.2–4
In most NPC cases, the neurological defects
begin to appear when patients are between 4 
and 10 years old.2 The symptoms are usually
clumsiness and gait disturbance at the begin-
ning, and include ataxia, mental disturbance,
dystonia, dysarthria, dysphagia, seizures and 
vertical supranuclear gaze palsy during the dis-
ease course.5–7 Death in NPC patients is usually
©2011 Elsevier & Formosan Medical Association
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Departments of 1Nuclear Medicine, 2Medical Imaging and 3Neurology, National Taiwan University Hospital and National
Taiwan University College of Medicine, Taipei, and 4Department of Nuclear Medicine and PET Center, China Medical
University Hospital, Taichung, Taiwan.
Received: March 20, 2009
Revised: April 30, 2009
Accepted: June 1, 2009
*Correspondence to: Dr Ruoh-Fang Yen, Department of Nuclear Medicine, National Taiwan
University Hospital, 7 Chung-Shan South Road, Taipei, Taiwan.
E-mail: rfyen@ntu.edu.tw
J.Y. Huang, et al
538 J Formos Med Assoc | 2011 • Vol 110 • No 8
caused by aspiration pneumonia.8,9 For the 
minority of adult-onset NPC patients, the typical
observed symptoms are psychiatric disorders
such as dementia, depression, bipolar disease or
schizophrenia.10
Mutations of the NPC1 gene, located on
chromosome 18q11–12, are observed in 95% of
NPC patients, whereas mutations of the NPC2
gene are noted in 5%.1,2 It has been proposed
that the mutations in the NPC genes cause block-
age of cholesterol transport between lysosomes
and the sterol regulator machinery, so that exces-
sive cholesterol is accumulated and apoptosis of
neurons occurs.1,11 The intracellular accumula-
tion of unesterified cholesterol in the lysosomal
system can be detected from the fluorescence
level around the nucleus, via filipin staining. To
reach a conclusive diagnosis of NPC, both the
abnormal accumulation of cholesterol and de-
layed low-density lipoprotein–cholesterol esteri-
fication in fibroblast cell culture should be
observed.12
For NPC, brain magnetic resonance imaging
(MRI) usually is not capable of detecting abnor-
mality, except in the late stages.6 Magnetic reso-
nance spectroscopy (MRS) is a noninvasive
neuroimaging technique for obtaining informa-
tion about brain metabolism. In general, decreased
N-acetyl aspartate indicates neuronal and axonal
loss, whereas increased choline reflects demyeli-
nation or gliosis.13,14 In addition, 18-fluoro-2-
deoxyglucose (F-18 FDG) positron emission
tomography (PET), based on glucose utilization
in the brain, is known to be sensitive for the de-
tection of metabolic derangements in patients
with neurodegenerative disorders. In this report,
we present the MRI, MRS and F-18 FDG PET im-
aging results for a 22-year-old male NPC patient.
Case Report
This patient was referred to our hospital when he
was 19 years old because of speech and swallowing
difficulty that had been progressing rapidly for
the past 6 months. His birth and development
history had been normal until age 11, when
lower extremity stiffness with difficulty in squat-
ting was noted. Since then, the patient’s symp-
toms of dysarthria and dysphagia started and his
school performance also began to deteriorate.
His older brother suffered from the same neuro-
logical onset at age 13 years and died at age 
19 years.
During the patient’s first admittance to our
hospital, his neurological examination revealed
diffuse spasticity, dystonia, limb and trunk ataxia,
vertical supranuclear gaze palsy, facial grimace,
mild rigidity in limbs, hyperactive deep tendon
reflexes, and limb dysmetria. No retinal pigmen-
tation abnormality was noted by the consulting
ophthalmologist. All other physical examination
results were normal.
The patient’s first brain MRI showed slightly
increased signal intensity in bilateral parietal–
occipital periventricular white matter (Figure 1A).
Single voxel proton MRS of the left frontal 
central white matter (TR/TE = 1500/270 millisec-
onds) showed no significant decrease in N-acetyl
aspartate/choline ratio (Figure 1B and 1C).
Cerebrospinal fluid analysis showed absence
of pleocytosis and normal protein and sugar levels.
Aspirates of bone marrow biopsy demonstrated a
significant increase in foamy cells. The diagnos-
tic result of NPC for this patient was confirmed
by filipin staining and cholesterol esterification
assay of skin fibroblasts performed by the National
Referral Laboratory, Adelaide, Australia. The results
showed the presence of perinuclear nonesterified
cholesterol deposits and a significantly reduced
rate of cholesterol esterification (1.4 pmol/hr/mg
protein, normal range: >3 pmol/hr/mg protein)
in cultured fibroblasts.
Although empirical treatment using lavostatin
(a hypolipidemic agent) for this patient was
given, his NPC symptoms still deteriorated grad-
ually. His worsening dysphagia eventually resulted
in frequent choking such that he was readmitted
for percutaneous gastrostomy with feeding tube
placement, at age 22 years; 3 years after initial di-
agnosis. The follow-up brain MRI revealed more
prominent brain atrophy, especially in the frontal
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lobes and more increased signal intensity in bilat-
eral parietal–occipital periventricular white matter
(Figure 1D).
Brain F-18 FDG PET was subsequently per-
formed and the axial views of PET images are
shown in Figure 2A, which reveals obvious hypo-
metabolism in the prefrontal cortex and thala-
mus. Figure 2B and 2C shows the statistical
parametric mapping (SPM99, Wellcome Depart-
ment of Cognitive Neurology, Institute of
Neurology, University College London) results
for the patient, compared with 10 age-matched
healthy controls with a height threshold of p =
0.001 (T=4.30), extent size threshold of p=0.005
(210 voxels), and uncorrected for multiple com-
parisons. The statistical parametric mapping re-
sults showed significant hypometabolism in the
prefrontal cortex and dorsomedial nucleus of the
thalamus (Figure 2B); and hypermetabolism in
the parietal–occipital white matter, lenticular nu-
cleus of the basal ganglia, cerebellum, and pons
(Figure 2C).
Discussion
Our findings demonstrate progressive changes 
in the patient’s two MR images and consistent
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Figure 1. (A) At age 19, fast-spin echo T2-weighted images (effective TR/effective TE=4700/93 milliseconds, echo train
length 90) in the axial plane at the level of both lateral ventricular bodies showed slightly increased signal intensity in bi-
lateral in parietal–occipital periventricular white matter (arrows). (B) At age 19, single-voxel, point-resolved spectroscopy
(TR/TE=1500/270 milliseconds) sampled at the left frontal central white matter. (C) Magnetic resonance spectroscopy
showed no significant decrease in N-acetyl aspartate/choline. (D) Follow-up fast-spin echo T2-weighted images at the
similar level at age 22 showed more prominent sulci of both cerebral convexities, especially in the frontal lobes (arrow-
heads), and more increased signal intensity in bilateral parietal–occipital periventricular white matter (arrows).
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findings in his MRI and F-18 FDG PET. These 
imaging results may be related to the clinical
manifestations and neuropathology of this NPC
patient. To the best of our knowledge, there are
only two previous reports with regard to the F-18
FDG PET findings in NPC patients.15,16
At age 22 years, MRI revealed brain atrophy,
especially in the frontal lobes, and F-18 FDG PET
showed hypometabolism in the frontal cortex.
The neuronal dysfunction of the frontal lobe in
this patient might have been responsible for the
imaging results. Hypometabolism in the prefrontal
cortex15,16 and thalamus15 has been reported and
is similar to the PET and MRS findings in this
case. Hypometabolism in the prefrontal cortex
and dorsomedial nucleus of the thalamus might
be related to cognition and intelligence impair-
ment. The dorsomedial nucleus is interconnected
with the prefrontal cortex and is known to play
important roles in prefrontal functions such as
affect and foresight.17 It has been reported that
most adult-onset NPC patients are referred to cli-
nicians due to behavior and mood changes or
some major psychiatric problems,9,10 and cogni-
tive impairment is one of the common initial 
deficiencies of NPC patients.6 These clinical man-
ifestations have been confirmed in a postmortem
analysis of NPC patients.16 This postmortem
neuropathological study showed non-amyloid
neurofibrillary tangles predominantly in the frontal
lobe and thalamus. It has been suggested that
perturbed cholesterol metabolism or lysosomal
membrane trafficking might affect the formation
of neurofibrillary tangles in NPC patients.18
Battisti et al15 have reported hypometabolism
in the cerebellum, whereas PET in our case re-
vealed hypermetabolism in the lenticular nu-
cleus of the basal ganglia, pons, and cerebellum.
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Figure 2. (A) Axial view of 18-fluoro-2-deoxyglucose positron
emission tomography images at age 22 showed obvious bilat-
eral hypometabolism in the prefrontal cortex and thalamus.
Statistical parametric mapping analysis (voxel height threshold
of p=0.001; extent size threshold of p=0.005; uncorrected
for multiple comparison) showed significant (B) hypometabo-
lism in the prefrontal cortex and dorsomedial nucleus of the
thalamus, and (C) hypermetabolism in the parietal–occipital
white matter, lenticular nucleus of the basal ganglia, cerebel-
lum, and the pons.
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Hypermetabolism was not reported in either of
the two previous studies. In our opinion, this
discrepancy may be attributed to the different
types or stages of NPC. In the study by Battisti et al,
the onset was at age 25 years (compared with 11
years in our patient), F-18 FDG PET was per-
formed at 33 years (22 years in our patient), and
MRI showed severe cerebellar atrophy (MRI did
not reveal this in our patient).
Hypermetabolism in the basal ganglia, mid
brain and cerebellum may be related to dystonia.
It has been observed that hyperperfusion in the
putamen is associated with dystonic posturing in
patients with temporal lobe epilepsy.19 Cerebellar
and pontine metabolic increases have been ob-
served in patients with essential blepharospasm,20
which is a focal dystonia. The patient’s peculiar
grimace is also a form of facial dystonia. These
types of hypermetabolic phenomena may be 
attributed to the abnormal metabolic networks,
as occur in patients with DYT1 dystonia.21
Significant hypermetabolism in the parietal–
occipital white matter in the present case report
was another PET finding that has not been 
noted before. MRI also showed increased signal
intensity in the same areas. White matter degen-
eration in NPC patients has been documented.22
In an animal model using NPC mice, demyelina-
tion has been observed in the early disease
course and is accompanied by marked gliosis
and reduced axon number.23 Using diffusion
tensor imaging, significant reduction in brain
water diffusion has also been observed in white
matter in an NPC patient.24 We suspect that 
the white matter hyperintensity with MRI and
hypermetabolism with PET in our case brings
forth possible evidence for active demyelination
in NPC.
Our results suggest that brain imaging offers a
possible supplementary explanation of the clini-
cal neurological symptoms in NPC patients. In
our opinion, these neuroimaging modalities
could provide an avenue to non-invasively study
correlation of NPC with its neuropathological
aspects. Further studies in more NPC patients are
needed to verify our assumptions.
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